Skip to main content
Industry

Spinout Spotlight: Stephen Strittmatter, M.D., Ph.D., A.B.

Stephen Strittmatter headshot
Vincent Coates Professor of Neurology and Professor of Neuroscience; Director, Cellular Neuroscience, Neurodegeneration and Repair; Director, Yale Alzheimer's Disease Research Center; Director, Memory Disorders Clinic

Yale Spinout Success Snapshot - ReNetXBio

  • Stephen Strittmatter, MD, PhD, the Vincent Coates Professor of Neurology and co-founded the Yale Program in Cellular Neuroscience, Neurodegeneration and Repair, is the scientific founder & a current advisor at ReNetX Bio.

  • They were established to provide first-in-class therapeutics to treat damage to the central nervous system (CNS).
  • ReNetX Bio has raised $25M, launched a Phase 1/2 clinical trial proof of concept trial and was granted "Fast Track Designation" from FDA.